Cardiac antiapoptotic and proproliferative effect of recombinant human erythropoietin in a moderate stage of chronic renal failure in the rat

OBJECTIVE: Recombinant human erythropoietin (rhEPO) therapy under circumstances of moderate chronic renal failure (CRF), with yet lower kidney and heart lesion, may have a protective cardiac effect beyond the correction of anemia, whose mechanism deserves better elucidation, namely by clarifying the...

Descripción completa

Detalles Bibliográficos
Autores principales: Teixeira, M., Rodrigues-Santos, P., Garrido, P., Costa, E., Parada, B., Sereno, J., Alves, R., Belo, L., Teixeira, F., Santos-Silva, A., Reis, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3283962/
https://www.ncbi.nlm.nih.gov/pubmed/22368404
http://dx.doi.org/10.4103/0975-7406.92743

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3283962/
https://www.ncbi.nlm.nih.gov/pubmed/22368404
http://dx.doi.org/10.4103/0975-7406.92743

Ejemplares similares